Literature DB >> 300226

Spectrum of immune response abnormalities in different clinical forms of tuberculosis.

R Bhatnagar, A N Malaviya, S Narayanan, P Rajgopalan, R Kumar, O P Bharadwaj.   

Abstract

In an attempt to explain the reasons for the development of different clinical forms of tuberculosis in different persons, their immunologic status was compared to their clinical patterns. The spectrum of immunologic abnormalities correlated with the clinical forms. Also, an inverse relationship between cell-mediated and humoral immune responses was observed. Immunologic abnormalities reverted to normal concomitant with clinical improvement on chemotherapy, suggesting that the abnormalities were the result of the illness rather than its cause. Malnutrition could have been the underlying factor for the immunologic deficiencies seen in some patients.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 300226     DOI: 10.1164/arrd.1977.115.2.207

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Immunosuppression by mycobacterial arabinomannan.

Authors:  J J Ellner; T M Daniel
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

2.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

3.  Tuberculous anergic sera or purified protein derivative treatment induces modification in lymphocyte transformation of cells from patients with tuberculosis.

Authors:  H Mejia-López; O Vaca-García; J M Cristerna-Aguirre; A Cruz-Chávez; M Selman-Lama; M L Taylor
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

4.  Deficient immune interferon production in tuberculosis.

Authors:  J K Onwubalili; G M Scott; J A Robinson
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

5.  Limiting dilution analysis of T cell unresponsiveness to mycobacteria in advanced disseminated tuberculosis.

Authors:  M S Gilardini Montani; F Del Gallo; G Lombardi; P Del Porto; E Piccolella; F Arienzo; V Colizzi
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

6.  Inhibition of mitogenesis induced by phytohemagglutinin and Lens culinaris lectin in adherent-cell supernatants treated with protein extract of Mycobacterium tuberculosis.

Authors:  C Parra; L F Montaño; M Huesca; I Rayón; K Willms; F Goodsaid
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

7.  Contact sensitisation to DNCB.

Authors:  S Rajajee; P R Narayanan
Journal:  Indian J Pediatr       Date:  1988 May-Jun       Impact factor: 1.967

8.  A longitudinal study of antibody titres to Antigen 6 in patients with bone and joint tuberculosis.

Authors:  J H Lau; J C Leong; A B Stroebel
Journal:  Int Orthop       Date:  1983       Impact factor: 3.075

9.  Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls.

Authors:  F O Sánchez; J I Rodríguez; G Agudelo; L F García
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes.

Authors:  J Gercken; J Pryjma; M Ernst; H D Flad
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.